美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · LFCR近 30 天 2 則 · 第 1 / 1 頁
- Lifecore Biomedical to Participate at CPHI Global Conference
- Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
- Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
- Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
- Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary
- Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...
- Lifecore Biomedical Q2 Earnings Call Highlights
- Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
- Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
- Lifecore Biomedical Signs Three New Customer Agreements
- Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
- Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
- Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
- Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
- Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
- How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
- Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
- Lifecore Biomedical to Participate at CDMO Live Europe
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。